OncoMed Pharmaceuticals Inc (OMED)

12.14
0.35 2.97
NASDAQ : Health Care
Prev Close 11.79
Open 11.93
Day Low/High 11.71 / 12.18
52 Wk Low/High 8.42 / 23.98
Volume 116.22K
Avg Volume 206.50K
Exchange NASDAQ
Shares Outstanding 30.67M
Market Cap 369.59M
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For OncoMed Pharmaceuticals (OMED)

Oversold Conditions For OncoMed Pharmaceuticals (OMED)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Noteworthy Monday Option Activity: OMED, ISRG, STAA

Noteworthy Monday Option Activity: OMED, ISRG, STAA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in OncoMed Pharmaceuticals Inc. , where a total volume of 510 contracts has been traded thus far today, a contract volume which is representative of approximately 51,000 underlying shares (given that every 1 contract represents 100 underlying shares).

Short Interest In OncoMed Pharmaceuticals Moves 18% Higher

Short Interest In OncoMed Pharmaceuticals Moves 18% Higher

The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 350,042 share increase in total short interest for OncoMed Pharmaceuticals Inc. , to 2,303,320, an increase of 17.92% since 07/15/2016.

Commit To Purchase OncoMed Pharmaceuticals At $10, Earn 29.6% Annualized Using Options

Commit To Purchase OncoMed Pharmaceuticals At $10, Earn 29.6% Annualized Using Options

Investors considering a purchase of OncoMed Pharmaceuticals Inc. stock, but tentative about paying the going market price of $12.31/share, might benefit from considering selling puts among the alternative strategies at their disposal.

5 Best-Positioned Biotech Stocks on Brexit Volatility

5 Best-Positioned Biotech Stocks on Brexit Volatility

Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.

Commit To Purchase OncoMed Pharmaceuticals At $12.50, Earn 23% Annualized Using Options

Commit To Purchase OncoMed Pharmaceuticals At $12.50, Earn 23% Annualized Using Options

Investors eyeing a purchase of OncoMed Pharmaceuticals Inc. shares, but cautious about paying the going market price of $14.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.

7 Stocks Under $10 Making Big Breakout Moves

7 Stocks Under $10 Making Big Breakout Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakouts.

OncoMed Provides Update On Tarextumab Phase 2 Programs

OncoMed Provides Update On Tarextumab Phase 2 Programs

Phase 2 PINNACLE Study in Small Cell Lung Cancer Continues Following DSMB and FDA Review